Related Experiment Video
Updated: Sep 24, 2025

Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
The long β2,3-sheets encoded by redundant sequences play an integral role in the channel function of P2X7 receptors
Xue-Fei Ma1, Ting-Ting Wang2, Wen-Hui Wang2
1College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha, China; School of Basic Medicine and Clinical Pharmacy and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
Abstract:
P2X receptors are a class of nonselective cation channels widely distributed in the immune and nervous systems, and their dysfunction is a significant cause of tumors, inflammation, leukemia, and immune diseases. P2X7 is a unique member of the P2X receptor family with many properties that differ from other subtypes in terms of primary sequence, the architecture of N- and C-terminals, and channel function. Here, we suggest that the observed lengthened β2- and β3-sheets and their linker (loop β2,3), encoded by redundant sequences, play an indispensable role in the activation of the P2X7 receptor. We show that deletion of this longer structural element leads to the loss of P2X7 function. Furthermore, by combining mutagenesis, chimera construction, surface expression, and protein stability analysis, we found that the deletion of the longer β2,3-loop affects P2X7 surface expression but, more importantly, that this loop affects channel gating of P2X7. We propose that the longer β2,3-sheets may have a negative regulatory effect on a loop on the head domain and on the structural element formed by E171 and its surrounding regions. Understanding the role of the unique structure of the P2X7 receptor in the gating process will aid in the development of selective drugs targeting this subtype.
Insights
The P2X7 receptor
Area of Science:
- Ion channel research
- Molecular biology
- Cellular signaling
Background:
- P2X receptors are nonselective cation channels crucial in immune and nervous systems.
- P2X receptor dysfunction is linked to diseases like cancer, inflammation, and leukemia.
- P2X7 receptors possess unique structural and functional characteristics compared to other subtypes.
Purpose of the Study:
- Investigate the role of a specific structural element (lengthened β2- and β3-sheets and their linker, loop β2,3) in P2X7 receptor activation.
- Determine the impact of this structural element on P2X7 channel function, surface expression, and gating.
Main Methods:
- Site-directed mutagenesis
- Chimera construction
- Surface expression analysis
- Protein stability assays
Main Results:
- Deletion of the longer β2,3-loop resulted in the loss of P2X7 receptor function.
- The β2,3-loop deletion impacted P2X7 surface expression.
- Crucially, the β2,3-loop was found to affect P2X7 channel gating.
Conclusions:
- The lengthened β2,3-sheets and loop β2,3 are essential for P2X7 receptor activation and function.
- This structural element plays a critical role in regulating P2X7 channel gating.
- Understanding the P2X7 structure-function relationship can guide the development of targeted therapeutics.
More Related Videos
Related Concept Videos
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
GPCR Desensitization
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Single-pass Transmembrane Proteins

